The role of health technology assessment under the personalised medicine approach

Health Technology Assessment (HTA) on Personalised Medicine (PM) focuses on assessing the effectiveness, safety, and cost-effectiveness of diagnostic tools and treatments tailored to individual patients based on their genetic,
environmental, and lifestyle factors. HTA can provide important information to support decision-making in the adoption, funding, and use of these technologies in clinical practice.

Friday, April 14, 2023
10:30 AM CET; 12.30 AM EAT; 9:30 AM GMT
Register here: